Safety of sodium hyaluronate eye drop with C12-benzalkonium chloride

PURPOSE: In this study, we investigated the effects of commercially available multi-dose sodium hyaluronate 0.1% (Hyalein®; Santen, Osaka, Japan) containing 0.003% C12-benzalkonium chloride (BAC) on the Corneal epithelium and its degree of safety.

METHODS: Japanese white male rabbits were divided into four groups. The corneas of each group exposed to one of the following solutions: sodium hyaluronate 0.1%, C12-BAC, C12, 14, 16-BAC Mixture, and Hank's Balanced Salt Solution (HBSS) (as control), respectively. Corneal transepithelial electrical resistance (TER) changes after 60 s of exposure to the above solutions were measured in living rabbits. TER reflects the barrier function of the epithelium. In addition, scanning electron microscopy was used to examine the acute effects of the above solutions on the integrity of the corneal epithelium of four groups.

RESULTS: There was no significant decrease in the corneal TER after exposure of the cornea to Hyalein® eye drops as compared to HBSS control eyes. Also, BAC mixture solution and C12-BAC did not produce any significant decrease in the corneal TER as compared to HBSS control eyes. All the corneal epithelium exposed to Hyalein®, 0.003% C12-BAC and 0.003% BAC mixture exhibited a regular appearance of the superficial cells with a high density of microvilli.

CONCLUSION: This study confirms that Hyalein® has no acute hazardous effect on corneal epithelium.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Cutaneous and ocular toxicology - 38(2019), 2 vom: 01. Juni, Seite 156-160

Sprache:

Englisch

Beteiligte Personen:

Mohamed, Yasser Helmy [VerfasserIn]
Uematsu, Masafumi [VerfasserIn]
Ueki, Ryotaro [VerfasserIn]
Inoue, Daisuke [VerfasserIn]
Sasaki, Hitoshi [VerfasserIn]
Kitaoka, Takashi [VerfasserIn]

Links:

Volltext

Themen:

9004-61-9
Alkyl chain length
Benzalkonium Compounds
Benzalkonium chloride
Cornea
Hyalein
Hyaluronic Acid
Journal Article
Ophthalmic Solutions
Preservatives, Pharmaceutical
Sodium hyaluronate
Transepithelial electrical resistance

Anmerkungen:

Date Completed 08.08.2019

Date Revised 08.08.2019

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/15569527.2018.1543316

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM290373727